FOXO TECHNOLOGIES INC

Agape ATP

Liminatus Pharma

Tradr 2X Long QBTS Daily ETF

Wheeler Real Estate

Tradr 2X Long RGTI Daily ETF

NewGenIvf

Defiance Daily Target 2X Long RGTI ETF

Sunshine Biopharma

Co-Diagnostics

Infleqtion

FOXOW

Earnings Watch

FOXO TECHNOLOGIES INC | 10-K: FY2025 Revenue: USD 16.37 M

SBIO

FOXO

<p>FOXO Technologies Expands Authorized Class A Share Capacity</p>

Tip Ranks

SPDR S&P Biotech

VG Health

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

iShares US Healthcare Providers

SPDR S&P Health

FOXO Tech

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

Health Care Select Sector SPDR

iShares Global Healthcare

iShares Biotechnology ETF

FOXO Technologies Expands Authorized Class A Share Capacity

<p>FOXO Technologies has signed a Series E Preferred Stock Exchange Agreement with Rennova Health to convert $200,000 in cash advances into equity. The company will issue 8,000 shares of Series E Cumulative Redeemable Secured Preferred Stock at $25.00 per share, fully satisfying and cancelling the prior advances. This private placement agreement was effective on December 31, 2025, allowing FOXO to extinguish debt and convert short-term advances to preferred equity.</p>

TradingView

Proshares Ultra Nasdaq Biotech

Rennova Health, Inc.

FOXO Technologies Signs Series E Preferred Stock Exchange Agreement With Rennova Health

FOXO TECHNOLOGIES INC | 10-Q: FY2025 Q3 Revenue: USD 3.548 M

FOXO TECHNOLOGIES INC | 10-Q: FY2025 Q2 Revenue: USD 5.218 M

FOXO TECHNOLOGIES INC | 10-Q: FY2025 Q1 Revenue: USD 3.17 M